Učitavanje...

The progress of targeted therapy in advanced gastric cancer

Although palliative chemotherapy has been shown to prolong survival and improve quality of life, the survival of advanced gastric cancer (AGC) patients remains poor. With the advent of targeted therapy, many molecular targeted agents have been evaluated in clinical studies. Trastuzumab, an anti-HER2...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Qiu, Miao-zhen, Xu, Rui-hua
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2013
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3878836/
https://ncbi.nlm.nih.gov/pubmed/24330856
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2050-7771-1-32
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!